Medagama Arjuna Bandara, Widanapahirana Heshan, Prasanga Tharindu
Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
J Intercult Ethnopharmacol. 2015 Oct-Dec;4(4):264-9. doi: 10.5455/jice.20151104093108. Epub 2015 Nov 8.
There is an increase of over-the-counter (OTC) herbal products for use in diabetes mellitus. The aim of this study is to evaluate the safety information provided with OTC herbal remedies intended for diabetic patients in Sri Lanka and to assess the completeness of the information provided.
Inclusion criteria consisted of OTC herbal remedies meant for use in diabetes. They were bought from local Sri Lankan supermarkets and non-ayurvedic pharmacies and product information regarding the risk of hypoglycemia, precautions for use, adverse events, dose, and interactions were assessed using a scoring system. The accuracy of the information was then compared against published data.
11 products fulfilled the inclusion criteria. Five products contained a single constituent and five contained more than one. None had complete and accurate safety information according to our criteria. None specifically warned against the risk of hypoglycemia. 9 out of 11 products (81.8%) carried ≤3 items of the five essential factual information we expected. Hypoglycemic coma, gastrointestinal symptoms, hepatotoxicity, carcinogenesis, and interactions causing elevated drug levels of Carbamazepine were some of the safety information that was missing.
Key safety information was absent in most products. Regulation of sale, provision of key safety information and adverse event reporting should be a priority.
用于糖尿病的非处方(OTC)草药产品有所增加。本研究的目的是评估斯里兰卡为糖尿病患者提供的非处方草药疗法的安全信息,并评估所提供信息的完整性。
纳入标准包括用于糖尿病的非处方草药疗法。这些产品从斯里兰卡当地超市和非阿育吠陀药房购买,并使用评分系统评估有关低血糖风险、使用注意事项、不良事件、剂量和相互作用的产品信息。然后将信息的准确性与已发表的数据进行比较。
11种产品符合纳入标准。5种产品含有单一成分,5种产品含有一种以上成分。根据我们的标准,没有一种产品具有完整准确的安全信息。没有一种产品特别警告低血糖风险。11种产品中有9种(81.8%)包含我们期望的五项基本事实信息中的≤3项。低血糖昏迷、胃肠道症状、肝毒性、致癌作用以及导致卡马西平药物水平升高的相互作用是一些缺失的安全信息。
大多数产品缺乏关键安全信息。销售监管、关键安全信息的提供和不良事件报告应成为优先事项。